Diagnostic News and Research

RSS

ADMT announces filing of FDA 510(k) application for Angiodroid The CO2 Injector for Angiography

ADM Tronics Unlimited, Inc. has announced that a Premarket Notification 510(k) application has been filed with the US Food and Drug Administration for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector") by Angiodroid America, Inc., a subsidiary of Angiodroid, Srl, in affiliation with Triotech Ventures and ADMT, as previously announced.

15 Oct 2015

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

VolitionRx Limited today announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society.

14 Oct 2015

New tool may help identify high risk atherosclerotic plaques

Researchers have developed and validated a new tool to help identify unstable or high risk atherosclerotic plaques--inflamed fatty deposits in the artery wall and a main contributor to cardiovascular disease (CVD). This breakthrough may lead to better identifying which plaques are considered at the highest risk for rupturing and causing a heart attack or stroke.

14 Oct 2015

RE.WORK showcases future technology and innovations in deep learning software

The future of technological innovation is a broad topic with endless opportunities in every scientific field. RE.WORK’s two most recent concurrent conferences ‘RE.WORK: Future Technology’ and ‘RE.WORK: Deep Learning’, in part focussed on putting healthcare in the context of the wider technological revolution.

13 Oct 2015

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.

13 Oct 2015

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.

From Quest Diagnostics 13 Oct 2015

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx immunohistochemistry test, available through Dako, an Agilent Technologies company.

From Quest Diagnostics 13 Oct 2015

Diabetes screening process needs 'careful re-evaluation'

The process for screening for Type 2 diabetes or those at high risk of the condition needs "careful re-evaluation", according to the first study on the effectiveness of testing methods.

13 Oct 2015

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Gensignia Life Sciences, Inc. (Gensignia) announced today that it received certification under the Clinical Laboratory Improvement Amendments (CLIA).

13 Oct 2015

Penn researchers lay groundwork for developing lncRNA-based tools for new cancer treatment

Growing insights about a significant, yet poorly understood, part of the genome - the "dark matter of DNA" -- have fundamentally changed the way scientists approach the study of diseases.

13 Oct 2015

Pregnant women with elevated blood-sugar levels more likely to have babies with heart defects

Pregnant women with elevated blood-sugar levels are more likely to have babies with congenital heart defects, even if their blood sugar is below the cutoff for diabetes, according to a new study from the Stanford University School of Medicine and Stanford Children's Health.

12 Oct 2015

Study identifies four distinct types of bowel cancer

Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.

12 Oct 2015

Is dyspraxia a battle of the sexes?

New findings released Monday 12 October 2015 have revealed a significant gap in the diagnosis – and therefore, treatment – of dyspraxia, otherwise known as developmental co-ordination disorder (DCD), amongst young women and girls.

12 Oct 2015

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

Astute Medical, Inc. today announced the signing of an agreement with Shanghai Fosun Long March Medicine Science Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd., for distribution of Astute's NephroCheck Test on the Astute140 Meter in China. In addition to its planned launch of the NephroCheck Test in China, FOSUNPHARMA invested $20 million in Astute.

12 Oct 2015

York scientists target specific sodium channel to prevent breast cancer

Scientists at the University of York, using clinical specimens from charity Breast Cancer Now's Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.

12 Oct 2015

ImmunArray launches SLE-key Rule-Out test for lupus patients

Following a limited three-month trial period in which more than one hundred and fifty patients with lupus-like symptoms were tested for the difficult-to-diagnose disease, a new blood test for lupus is being rolled out nationally.

12 Oct 2015

Fraunhofer researchers developing new system for rapid analysis of urinary stones

Kidney stones rank among the most common illnesses. Their recurrence might be prevented with the right postoperative care. However, for this to be effective, composition of the stones should be known. Fraunhofer researchers are developing a system for rapid analysis of urinary stones immediately after the surgical procedure.

12 Oct 2015

Artificial lung model could provide better understanding of health risks associated with airborne pollution

A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).

9 Oct 2015

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Despite decades of study, schizophrenia has remained stubbornly difficult to diagnose in its earliest stage - between the appearance of symptoms and the development of the disorder. Now, a new analysis led by researchers at the UNC School of Medicine and the Renaissance Computing Institute identified illogical thoughts as most predictive of schizophrenia risk.

9 Oct 2015

Leading experts to discuss role of laboratory medicine in personalized medicine

Join the American Association for Clinical Chemistry (AACC) and leading experts in laboratory medicine and diagnostic testing for a discussion of how laboratory medicine is driving the future of personalized medicine and the policies to support these new technologies.

9 Oct 2015

Diagnostic News and Research

ADMT announces filing of FDA 510(k) application for Angiodroid The CO2 Injector for Angiography

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

New tool may help identify high risk atherosclerotic plaques

RE.WORK showcases future technology and innovations in deep learning software

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Diabetes screening process needs 'careful re-evaluation'

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Penn researchers lay groundwork for developing lncRNA-based tools for new cancer treatment

Pregnant women with elevated blood-sugar levels more likely to have babies with heart defects

Study identifies four distinct types of bowel cancer

Is dyspraxia a battle of the sexes?

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

York scientists target specific sodium channel to prevent breast cancer

ImmunArray launches SLE-key Rule-Out test for lupus patients

Fraunhofer researchers developing new system for rapid analysis of urinary stones

Artificial lung model could provide better understanding of health risks associated with airborne pollution

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Leading experts to discuss role of laboratory medicine in personalized medicine

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News